Portfolio Spotlight Ep 8: Powering the Next Wave of Edge AI: Ambiq’s Journey from Breakthrough to IPO
Three out of every four smartwatches in the world run on Ambiq chips. With more than 280 million devices powered globally, the US-headquartered semiconductor innovator has redefined what’s possible for wearables.
- 26 02 2026
- |
Portfolio Spotlight Ep 4: AlphaSense with APAC Regional Director, Mark Leadercramer
We’re back with another Portfolio Spotlight, this time on AlphaSense— a cutting-edge market intelligence and search platform powered by AI. With just a few clicks, AlphaSense delivers valuable insights from a trusted universe of public and private content. 🇸🇬 Despite being in Singapore for less than a year, AlphaSense has already grown to a team of over 50 full-time employees 🚀 We had the pleasure of sitting down with Mark Leadercramer, APAC’s Regional Director, to discuss the opportunities in the region and the unique solutions AlphaSense offers.
- 30 08 2024
- |
All
Stories & Videos
Insights & Trends
Portfolio News
Announcements
E-Newsletters
Events
All News & Insights
VAST Data Valued at $30 Billion as AI Drives a New Infrastructure Stack
- 22 04 2026
- |
Southeast Asian startups total funding surges 110 percent year on year to $2.8B in Q1 – Tracxn
- 15 04 2026
- |
Addepar Expands in Singapore as APAC Demands Reshape Data and AI Workflows
- 15 04 2026
- |
Thai AI startup Amity announces US$100 million Series D funding round; launches R&D centre in Singapore
- 25 03 2026
- |
New R&D facility to build next-generation equipment targeting Singapore-based chip giants
- 18 03 2026
- |
Semiconductor firm Ambiq to expand R&D in Singapore, eyes 30 specialised tech hires
- 26 02 2026
- |
Portfolio Spotlight Ep 8: Powering the Next Wave of Edge AI: Ambiq’s Journey from Breakthrough to IPO
- 26 02 2026
- |
CesiumAstro Closes $470M in Series C Capital for Rapid U.S. Growth in 2026
- 02 02 2026
- |
Revolut to triple its Singapore workforce to over 300 employees in the next three years
- 02 02 2026
- |
Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation
- 28 01 2026
- |
